On April 14, 2022 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products in oncology, anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapies, reported that it will present at NobleCon18, Noble Capital Markets’ 18th Annual Investor Conference being held April 19-21, 2022 (Press release, Citius Pharmaceuticals, APR 14, 2022, View Source [SID1234612259]). Leonard Mazur, Executive Chairman of Citius, will discuss recent business developments and upcoming milestones.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
NobleCon18 Conference
Date:
Wednesday, April 20, 2022 at 1:30 p.m. EST
Breakout sessions:
Wednesday, April 20 at 12:15 p.m.
Thursday, April 21 at 10:00 a.m.
Location:
Hard Rock Hotel & Casino, Hollywood, Florida
Registration:
Visit the conference website
Webcast replay:
Available beginning April 21 for 90 days; archived under "Events" in the Investors section of the Citius website